Published in Medical Letter on the CDC and FDA, August 22nd, 2004
The group of products includes ALLOMATRIX C, ALLOMATRIX Custom, and ALLOMATRIX DR bone graft putties that contain demineralized bone matrix (DBM) and specific volumes and configurations of donor matched, cancellous bone chips.
Following the FDA-clearance of ALLOMATRIX Injectable Putty in March of this year, today's regulatory announcement completes the clearance process for Wright's entire ALLOMATRIX family of products.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.